XML 65 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies - Additional Information (Detail)
1 Months Ended 12 Months Ended
Mar. 09, 2018
Oct. 31, 2017
USD ($)
Dec. 31, 2019
USD ($)
Segment
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 01, 2019
USD ($)
Significant Accounting Policies [Line Items]            
Reverse stock split     the Company effected a reverse split of all shares of its common and preferred stock at a ratio of 1-for-3.96      
Reverse stock split ratio 0.2525          
Number of operating segments | Segment     1      
Number of reportable segments | Segment     1      
Accumulated deficit     $ (205,326,000) $ (122,828,000)    
Minimum            
Significant Accounting Policies [Line Items]            
Property and equipment, estimated useful lives     1 year      
Impairment charges     $ 0 0    
Maximum            
Significant Accounting Policies [Line Items]            
Property and equipment, estimated useful lives     5 years      
Taiho Agreement | Taiho Pharmaceutical Co Ltd            
Significant Accounting Policies [Line Items]            
Accumulated deficit       2,200,000    
Non-refundable upfront research and development fees term     5 years      
Transaction price           $ 35,000,000
Non refundable and non creditable upfront cash payment received     $ 35,000,000      
Payment received for license agreement   $ 5,000,000 5,000,000 5,000,000 $ 25,000,000  
Additional payment to be received for license agreement     $ 5,000,000 5,000,000    
Net reduction to deferred revenue       $ 2,200,000    
Estimated performance period     5 years 4 years 5 years  
Before Adoption of Topic 606            
Significant Accounting Policies [Line Items]            
Accumulated deficit       $ (122,828,000)    
Before Adoption of Topic 606 | Taiho Agreement | Taiho Pharmaceutical Co Ltd            
Significant Accounting Policies [Line Items]            
Additional payment to be received for license agreement       $ 5,000,000    
Non-refundable, non-creditable cash payment received         $ 25,000,000  
ASC 606            
Significant Accounting Policies [Line Items]            
Accumulated deficit           (120,616,000)
Non-refundable upfront research and development fees term     5 years      
ASC 606 | Adjustment due to The Adoption of Topic 606            
Significant Accounting Policies [Line Items]            
Accumulated deficit           $ 2,212,000